Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, has announced the completion of a $5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada.
read more
Monday, November 26, 2018
Dalton Pharma announced a drug development and manufacturing services agreement with ExCellThera, a biotechnology company focused on delivering molecules and bioengineering solutions.
read more
Wednesday, January 28, 2015
Dalton Pharma Services today announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing.
read more
Tuesday, September 11, 2018
As a part of a 10 million dollar facility and capital expansion, Dalton Pharma Services has invested in a fully automated Sterile Liquid Filling System that will become operational in Q1 of 2019.
read more
Dalton Pharma Services has successfully received a ‘Compliant’ rating from the Health Products and Food Branch Inspectorate of Health Canada.
read more
Thursday, October 29, 2020
Dalton Pharma Services has been recognized for the 5th straight year as a Great Place to Work® in Canada.
read more
Dalton Pharma Services announced that the FDA completed a PAI inspection of its Health-Canada licensed manufacturing facility in Canada, in January 2019.
read more
Wednesday, December 21, 2016
Dalton Pharma Services has entered into a contract service agreement with the United States Army Medical Materiel Development Activity (USAMMDA) in support of the US Army’s product development program for the treatment of severe or complicated ...
read more
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
Danaher has entered into a definitive agreement with General Electric Company (GE) to acquire the Biopharma business of GE Life Sciences (GE Biopharma) for a cash purchase price of approximately $21.4 billion.
read more
Dante Labs, Cambridge Cancer Genomics, and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have signed a collaboration agreement.
read more
Tuesday, September 01, 2020
Daré Bioscience and Avomeen announced the companies have signed an agreement under which Avomeen will provide contract product development laboratory services with a team specifically assembled to support the advancement of Daré’s pipeline of ...
read more
Wednesday, August 22, 2018
DarioHealth has entered into an agreement with Attain Health to pilot the DarioEngage platform for the management of cystic fibrosis related diabetes (CFRD).
read more
Wednesday, September 18, 2019
Darmerica is voluntarily recalling two lots, DR4654A and DL4654A, of Quinacrine Dihydrochloride, bulk API powder packaged in Amber HDPE Bottles to the consumer level.
read more
DARTS has obtained an exclusive license for the DARTS patent and is the sole provider of the technology designed to streamline drug development and save pharmaceutical and biotech company’s time and money by identify a drug’s target of actions.
read more